Home Cart Sign in  
Chemical Structure| 1222800-79-4 Chemical Structure| 1222800-79-4

Structure of ML324
CAS No.: 1222800-79-4

Chemical Structure| 1222800-79-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML324 is an inhibitor of JMJD2 demethylase with IC50 of 920 nM with antiviral activity.

Synonyms: CID-44143209

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML324

CAS No. :1222800-79-4
Formula : C21H23N3O2
M.W : 349.43
SMILES Code : O=C(NCCCN(C)C)C1=CC=C(C2=CC(O)=C3N=CC=CC3=C2)C=C1
Synonyms :
CID-44143209
MDL No. :MFCD28053518
InChI Key :QDBVSOZTVKXUES-UHFFFAOYSA-N
Pubchem ID :44143209

Safety of ML324

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of ML324

epigenetics

Isoform Comparison

Biological Activity

Target
  • KDM4

    JMJD2, IC50:920 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 macrophages 50 μM 1-hour pretreatment followed by 24 hours Aa-LPS stimulation To investigate the mechanism of KDM4B inhibition-induced immunosuppression. Results showed ML324 pretreatment significantly increased H3K4me levels, reversing the Aa-LPS-induced decrease in H3K4me. PMC6260135
Bone marrow-derived osteoclast progenitors 10 μM 1-hour pretreatment followed by 72 hours Aa-LPS or RANK-L stimulation To evaluate the effect of ML324 on Aa-LPS or RANK-L-induced osteoclastogenesis. Results showed ML324 pretreatment significantly reduced osteoclast formation. PMC6260135
Primary murine macrophages 50 μM 1-hour pretreatment followed by 8 and 24 hours Aa-LPS stimulation To evaluate the effect of ML324 on Aa-LPS-induced inflammatory cytokine release. Results showed ML324 significantly reduced IL-6 and TNF-α transcription and translation. PMC6260135
CCB cells 20–50 µM 24 hours Completely block CyHV-3 replication PMC9863241
KF-1 cells 20–50 µM 24 hours Completely block CyHV-3 replication PMC9863241
Plasmodium falciparum early-stage gametocytes (stage II/III, EG) 0.188 μM 48 hours ML324 also showed inhibitory activity against early-stage gametocytes, though slightly less potent than against late-stage gametocytes PMC7801607
Plasmodium falciparum stage IV/V gametocytes 0.077 μM 48 hours ML324 significantly inhibited the viability of stage IV/V gametocytes by preventing histone demethylation, leading to aberrant gene expression and death in gametocytes PMC7801607
Plasmodium falciparum asexual blood stage parasites (ABS) 2.06 μM 72 hours ML324 exhibited lower inhibitory activity against asexual blood stage parasites, indicating selectivity towards gametocytes PMC7801607
Human MIBC organoids 5-40 μM ML324 inhibited human MIBC organoids growth in a dose-dependent manner with an estimated IC50 of 10 μM PMC11543538

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Inflammation model Intravenous injection 0.2 mg/kg Single injection, lasting 24 hours To investigate the blocking effect of ML324 on TNF-α-mediated neutrophil adhesion, results showed ML324 could block TNF-α-mediated neutrophil adhesion. PMC5361151
Koi CyHV-3 infection model Immersion bath 20 µM Daily for 3–4 h, within the first 5 days post-infection Significantly reduced CyHV-3 replication and mortality PMC9863241
Nude mice Orthotopic bladder cancer model Intraperitoneal injection 25 mg/kg Once daily for 9 days ML324 significantly inhibited bladder tumor growth, as evidenced by fluorescence intensity monitoring PMC11543538
Mice Depression model Intraperitoneal injection 30 mg/kg Once daily for 5 consecutive days ML324 treatment led to increased immobility time in the forced swim test, indicating depression-like behavior, and an increase in the transcriptionally repressive histone methylation mark H3K9me2 in NAc. PMC5312068

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.86mL

0.57mL

0.29mL

14.31mL

2.86mL

1.43mL

28.62mL

5.72mL

2.86mL

References

 

Historical Records

Categories